Balyasny Asset Management’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$590K Hold
12,138
– – ﹤0.01% 2483
2026
Q2
$655K Sell
12,138
-27,862
-70% -$1.56M ﹤0.01% 2409
2026
Q1
$2.61M Hold
40,000
– – ﹤0.01% 1670
2025
Q4
$3.48M Buy
+40,000
New +$4.29M ﹤0.01% 1583
2024
Q2
– Sell
-300
Closed -$17.7K – 3219
2024
Q1
$17.7K Buy
+300
New +$76.3K ﹤0.01% 2541

Other funds holding SPRB

Balyasny Asset Management's SPRB Position: Q3 2026 in Review

Balyasny Asset Management held its Spruce Biosciences (SPRB) position steady in Q3 2026 at 12,138 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

Balyasny Asset Management first reported a position in SPRB in Q1 2024 and has held it in 5 quarters since. The position peaked at $3.48M in Q4 2025. 70 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • Balyasny Asset Management held 12,138 shares of Spruce Biosciences worth $590K as of Q3 2026.
  • Balyasny Asset Management left its Spruce Biosciences share count unchanged in Q3 2026.
  • Spruce Biosciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q3 2026, its #2483 holding.
  • Balyasny Asset Management first reported a position in Spruce Biosciences in Q1 2024 and has held it in 5 quarters since.
  • Balyasny Asset Management's Spruce Biosciences position peaked at $3.48M in Q4 2025.
  • 70 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.